| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 15.034 | 19.064 | 18.049 | 21.987 | 14.628 | 29.827 | 24.678 | 25.617 | 35.204 |
| Total Income - EUR | - | 15.297 | 19.332 | 19.725 | 22.267 | 14.647 | 30.129 | 24.681 | 25.619 | 35.204 |
| Total Expenses - EUR | - | 4.088 | 11.585 | 31.385 | 25.455 | 18.604 | 32.149 | 33.140 | 35.932 | 31.139 |
| Gross Profit/Loss - EUR | - | 11.209 | 7.747 | -11.660 | -3.189 | -3.957 | -2.020 | -8.459 | -10.313 | 4.065 |
| Net Profit/Loss - EUR | - | 10.750 | 7.167 | -12.252 | -3.857 | -4.380 | -2.933 | -9.045 | -10.570 | 1.858 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Onco4Life Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 10.297 | 49.705 | 41.219 | 32.193 | 45.096 | 30.877 | 19.725 | 52.008 |
| Current Assets | - | 12.910 | 8.594 | 4.253 | 4.445 | 5.566 | 1.479 | 5.713 | 5.849 | 4.033 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 635 | 1.156 | 2.844 | 2.451 | 1.738 | 511 | 5.245 | 3.986 | 3.714 |
| Cash | - | 12.275 | 7.438 | 1.409 | 1.994 | 3.828 | 968 | 469 | 1.863 | 319 |
| Shareholders Funds | - | 10.795 | 17.779 | 5.200 | 1.243 | -3.161 | -6.023 | -15.087 | -25.611 | -23.610 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.115 | 1.112 | 48.757 | 44.420 | 40.920 | 52.598 | 51.678 | 51.185 | 79.972 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Onco4Life Srl